Sutro Biopharma Inc. (STRO)
1.45
-0.14 (-8.81%)
At close: Mar 03, 2025, 3:59 PM
1.52
5.20%
After-hours: Mar 03, 2025, 07:47 PM EST
Sutro Biopharma Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 69.27M | 47.25M | 30.41M | 206.15M | 4.96M | 125.3M | 22.02M | 11.59M |
| Short-Term Investments | 306.35M | 287.11M | 167.52M | 161.99M | 112.9M | 79.19M | n/a | 35.93M |
| Long-Term Investments | n/a | 32.02M | 68.78M | 872K | 15.61M | 15K | 223K | 482K |
| Other Long-Term Assets | 4.44M | 14.39M | 2.53M | 2.12M | 2.56M | 2.24M | 920K | 417K |
| Receivables | 36.08M | 7.12M | 12.45M | 5.56M | 6.3M | 2.49M | 1.62M | 577K |
| Inventory | n/a | -11.67M | 1.00 | n/a | n/a | 1.00 | n/a | n/a |
| Other Current Assets | 9.85M | 11.67M | 8.12M | 4.49M | 8.81M | 5.93M | 1.99M | 1.59M |
| Total Current Assets | 421.54M | 309.47M | 218.51M | 378.18M | 128.57M | 209.95M | 25.63M | 49.69M |
| Property-Plant & Equipment | 44.76M | 51.06M | 51.59M | 12.94M | 9.63M | 10.93M | 14M | 18.69M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 49.19M | 97.48M | 122.89M | 15.93M | 27.8M | 13.19M | 15.14M | 19.59M |
| Total Assets | 470.74M | 406.94M | 341.41M | 394.11M | 156.37M | 223.14M | 40.77M | 69.28M |
| Account Payables | 9.44M | 4.8M | 6.01M | 5.54M | 5.58M | 3.06M | 2.9M | 3.39M |
| Deferred Revenue | 20.67M | 106.64M | 5.5M | 14.6M | 19.46M | 21.57M | 10.71M | 43.58M |
| Short-Term Debt | 10.48M | 21.67M | 11.45M | n/a | 1M | 4.72M | 14.56M | n/a |
| Other Current Liabilities | 37.99M | 23.32M | 18.78M | 9.45M | 6.92M | 7.06M | 3.78M | 3.21M |
| Total Current Liabilities | 93.75M | 139.47M | 41.74M | 29.6M | 32.97M | 36.42M | 31.96M | 50.18M |
| Long-Term Debt | 23.15M | 33.34M | 46.96M | 24.55M | 8.88M | 10M | n/a | n/a |
| Other Long-Term Liabilities | 1.69M | 119K | 146K | 1.82M | 543K | 578K | 104.66M | 104.14M |
| Total Long-Term Liabilities | 227.34M | 50.43M | 47.11M | 32.47M | 25.61M | 55.18M | 117.81M | 110M |
| Total Liabilities | 321.09M | 189.9M | 88.84M | 62.06M | 58.58M | 91.6M | 149.77M | 160.18M |
| Total Debt | 33.63M | 67.52M | 57.37M | 24.55M | 9.88M | 14.72M | 14.63M | 1.19M |
| Common Stock | 61K | 58K | 46K | 46K | 23K | 23K | n/a | 16K |
| Retained Earnings | -559.41M | -452.62M | -333.41M | -227.87M | -195.75M | -150.33M | -115.01M | -95.32M |
| Comprehensive Income | 21K | -618K | -314K | 129K | 165K | -47K | -208K | -17K |
| Shareholders Equity | 149.65M | 217.05M | 252.56M | 332.05M | 97.79M | 131.54M | -109M | -90.9M |
| Total Investments | 306.35M | 287.11M | 236.3M | 161.99M | 128.51M | 79.19M | 223K | 35.93M |